Allied Market Research

2024

Japan Orphan Drugs Market

Japan Orphan Drugs Market Size, Share, Competitive Landscape and Trend Analysis Report by DISEASE TYPE and by INDICATION : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

  • Jun 2024

  • Pages: NA

  • Tables: NA

  • Charts: NA

Select an option
Online Only (10% Off) $3,690 $3,321
Data Pack/Excel (10% Off) $3,840 $3,456
Single User License (10% Off) $5,820 $5,238
Five User License (10% Off) $6,540 $5,886
Enterprise User License (10% Off) $9,870 $8,883
Library Membership (15% Off) $1,175 $999
Enquiry Now
Author's: | Roshan Deshmukh
Publish Date:
Enquire Before Buying Customization Request Speak with Analyst

Get Sample to Email

  Japan Orphan Drugs Market Report Highlights

Aspects Details
icon_5
By DISEASE TYPE
  • ONCOLOGIC DISEASES
  • METABOLIC DISEASES
  • HEMATOLOGIC AND IMMUNOLOGIC DISEASES
  • INFECTIOUS DISEASES
  • NEUROLOGIC DISEASES
  • OTHER RARE DISEASES
icon_6
By INDICATION
  • NON-HODGKIN LYMPHOMA
  • ACUTE MYELOID LEUKEMIA
  • CYSTIC FIBROSIS
  • GLIOMA
  • PANCREATIC CANCER
  • OVARIAN CANCER
  • MULTIPLE MYELOMA
  • DUCHENNE MUSCULAR DYSTROPHY
  • GRAFT VS HOST DISEASE
  • RENAL CELL CARCINOMA
  • Others
icon_7
Key Market Players

Daiichi Sankyo Company, Limited, Otsuka Pharmaceutical Co., Ltd., Astellas Pharma Inc., Shionogi & Co., Ltd., Merck KGaA, Pfizer, Inc., Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., Chugai Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd.

Loading Table Of Content...

Japan Orphan Drugs Market

Global Opportunity Analysis and Industry Forecast, 2023-2032

help@alliedmarketresearch.com